Nuo Therapeutics, Inc. financial data

Symbol
AURX on OTC
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91% % -49%
Quick Ratio 15% % -47%
Debt-to-equity -696% % -686%
Return On Equity 1030% %
Return On Assets -173% % -9.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,077,745 shares 3.2%
Common Stock, Shares, Outstanding 47,881,121 shares 2.8%
Entity Public Float $10,000,000 USD -72%
Common Stock, Value, Issued $4,788 USD 2.7%
Weighted Average Number of Shares Outstanding, Basic 47,539,384 shares 4.2%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) $2,566,545 USD -3.5%
Nonoperating Income (Expense) $2,223 USD
Net Income (Loss) Attributable to Parent $2,430,402 USD 2%
Earnings Per Share, Basic 0 USD/shares 17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $514,797 USD -25%
Accounts Receivable, after Allowance for Credit Loss, Current $652,252 USD 98%
Inventory, Net $201,627 USD 20%
Assets, Current $1,462,653 USD 8.9%
Property, Plant and Equipment, Net $347,022 USD 84%
Operating Lease, Right-of-Use Asset $117,962 USD -37%
Assets $1,927,637 USD 12%
Accounts Payable, Current $491,659 USD 28%
Accrued Liabilities, Current $390,892 USD 48%
Liabilities, Current $1,256,486 USD 76%
Operating Lease, Liability, Noncurrent $40,757 USD -64%
Liabilities $2,347,243 USD 183%
Retained Earnings (Accumulated Deficit) $34,193,682 USD -7.7%
Stockholders' Equity Attributable to Parent $419,606 USD -147%
Liabilities and Equity $1,927,637 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,825 USD
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $229,884 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 47,881,121 shares 2.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $228,059 USD 59%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $500,000 USD -27%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,716 USD 41%
Deferred Tax Assets, Valuation Allowance $40,740,054 USD -1.2%
Deferred Tax Assets, Gross $40,740,054 USD -1.2%
Operating Lease, Liability $114,692 USD -36%
Depreciation $73,067 USD 378%
Payments to Acquire Property, Plant, and Equipment $229,884 USD
Lessee, Operating Lease, Liability, to be Paid $124,058 USD -39%
Property, Plant and Equipment, Gross $841,414 USD 38%
Operating Lease, Liability, Current $73,935 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,285 USD -74%
Lessee, Operating Lease, Liability, to be Paid, Year One $82,705 USD 3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,366 USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Three $21,285 USD 0.01%
Deferred Tax Assets, Operating Loss Carryforwards $40,483,333 USD -1.1%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Additional Paid in Capital $33,769,288 USD 3.4%
Share-based Payment Arrangement, Expense $92,033 USD 184%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%